IRIS UniCatt

Rocca, Bianca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.958
EU - Europa 4.709
AS - Asia 4.231
SA - Sud America 1.159
AF - Africa 157
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.252
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.821
SG - Singapore 2.033
DE - Germania 1.307
CN - Cina 1.077
BR - Brasile 947
SE - Svezia 794
IT - Italia 612
UA - Ucraina 517
FR - Francia 312
IE - Irlanda 288
VN - Vietnam 205
ID - Indonesia 194
GB - Regno Unito 191
FI - Finlandia 156
IN - India 152
RU - Federazione Russa 138
PL - Polonia 135
HK - Hong Kong 100
AR - Argentina 93
TR - Turchia 87
BD - Bangladesh 71
CA - Canada 58
IQ - Iraq 54
ES - Italia 48
MX - Messico 48
JP - Giappone 39
KR - Corea 37
NL - Olanda 36
BE - Belgio 35
ZA - Sudafrica 34
AT - Austria 30
AU - Australia 30
EC - Ecuador 28
IR - Iran 27
CZ - Repubblica Ceca 26
CI - Costa d'Avorio 25
CO - Colombia 24
PK - Pakistan 22
SA - Arabia Saudita 20
VE - Venezuela 20
ET - Etiopia 19
CH - Svizzera 16
CL - Cile 14
PE - Perù 14
EG - Egitto 11
TN - Tunisia 11
JO - Giordania 10
MA - Marocco 10
PY - Paraguay 10
DZ - Algeria 9
IL - Israele 9
KE - Kenya 9
UZ - Uzbekistan 9
GH - Ghana 8
PH - Filippine 8
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
BG - Bulgaria 6
DO - Repubblica Dominicana 6
GR - Grecia 6
KW - Kuwait 6
KZ - Kazakistan 6
LV - Lettonia 6
MK - Macedonia 6
NO - Norvegia 6
NP - Nepal 6
TW - Taiwan 6
AL - Albania 5
HN - Honduras 5
LT - Lituania 5
MY - Malesia 5
NG - Nigeria 5
RO - Romania 5
SN - Senegal 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
MN - Mongolia 4
PT - Portogallo 4
AO - Angola 3
BH - Bahrain 3
CR - Costa Rica 3
HU - Ungheria 3
JM - Giamaica 3
MT - Malta 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BJ - Benin 2
GE - Georgia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
Totale 15.226
Salva come PNG Salva come JPEG
Città #
Singapore 788
Chandler 658
Ashburn 657
Dublin 280
Jacksonville 258
Beijing 229
San Mateo 225
Jakarta 169
Wilmington 164
Nanjing 152
Rome 122
Los Angeles 121
Warsaw 121
Woodbridge 120
Ann Arbor 106
New York 104
Hefei 101
Milan 100
Houston 98
Munich 97
Boston 96
Hong Kong 93
Lawrence 92
Cattolica 88
Dearborn 71
Fairfield 70
Ho Chi Minh City 70
Chicago 66
Moscow 66
São Paulo 64
Seattle 60
Nürnberg 59
Redwood City 59
Princeton 53
Izmir 48
Frankfurt am Main 47
Hanoi 47
Dallas 46
Buffalo 38
Nanchang 38
Tianjin 35
Nuremberg 33
Shenyang 33
Mountain View 32
Kent 29
Seoul 28
Brussels 27
Boardman 26
Santa Clara 26
Turku 26
University Park 26
Abidjan 25
Redmond 25
Hangzhou 24
Hebei 24
Hyderabad 24
Zhengzhou 24
Bremen 23
Brno 22
Brooklyn 22
Helsinki 22
Kunming 22
Belo Horizonte 21
London 21
Pune 21
Rio de Janeiro 21
Brasília 20
Detroit 20
Shanghai 19
Tokyo 19
Guangzhou 18
Bareggio 17
Cambridge 17
Dhaka 17
Johannesburg 17
Wayne 17
Augusta 16
Denver 16
Federal 16
Hounslow 16
Mexico 16
Phoenix 16
Tobarra 16
Vienna 16
Busto Arsizio 15
Fremont 15
Leawood 15
Marseille 15
The Dalles 15
Baghdad 14
Norwalk 14
Stockholm 14
Washington 14
Amsterdam 13
Atlanta 13
Montreal 13
Porto Alegre 13
Curitiba 12
Jiaxing 12
Manchester 12
Totale 7.131
Salva come PNG Salva come JPEG
Nome #
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 304
More, more, more: Reducing thrombosis in acute coronary syndromes beyond dual antiplatelet therapy-current data and future directions 271
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 247
Mean Platelet Volume, Platelet Distribution Width, and Platelet Count in Type 2 Diabetes Mellitus, Impaired Fasting Glucose, and Metabolic Syndrome: systematic review and meta-analysis 237
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study. 182
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 178
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 177
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 177
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study 174
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 158
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 156
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 154
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis 153
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 152
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13. A new prothrombotic mechanism associated with oxidative stress 147
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice 145
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 145
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 141
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 137
Effect of fibrinogen concentration on the velocity of platelet aggregation. 136
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 136
Increased thromboxane biosynthesis in essential thrombocythemia. 135
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 132
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 121
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 116
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 113
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis 113
Drug insight: aspirin resistance- fact or fashion 112
Aspirin: promise and resistance in the new millennium. 110
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes 110
Aspirin, stroke and drug-drug interactions 110
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 109
Determinants of the interindividual variability in response to antiplatelet drugs. 109
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia 109
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 109
Another family with IGPS 107
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 107
Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. 106
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 106
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 106
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 105
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. 105
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis 104
Fechtner syndrome: report of a third family and literature review 102
Homocysteinemia is inversely correlated with platelet count and inversely correlated with sE-and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase 102
Type 2 Diabetes, Obesity, and Aspirin Responsiveness* 101
Eicosanoid biosynthesis and metabolism in myeloproliferative disorders 100
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 100
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 99
Platelet progenitors: the hidden drug target 99
Identifying determinants of variability to tailor aspirin therapy 98
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective 98
Inherited macrothrombocytopenia with distinctive platelet ultrastructural and functional features 97
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 97
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythemia 97
Farmaci antipiastinici 97
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 97
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 96
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis 95
Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment 94
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 94
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 93
The future of antiplatelet therapy in cardiovascular disease 93
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 93
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 92
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 92
Effect of ketorolac, ketoprofen and nefopam on platelet function 91
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 90
Role of prostacyclin in the cardiovascular response to thromboxane A2 89
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects 89
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease 87
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 86
The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis 86
Cyclooxygenases and prostaglandins: shaping up the immune response 85
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 84
Aspirin and Other COX-1 Inhibitors 84
MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation 84
Farmaci Antipiastrinici 84
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 83
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors 83
Familial autoimmune myasthenia gravis with different pathogenetic antibodies 83
Wiskott-Aldrich syndrome: report of an autosomal dominant variant 83
The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin 82
Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation 82
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 82
LACK OF AN ASSOCIATION BETWEEN INHERITED THROMBOPHILIC RISK FACTORS AND IDIOPATIC SUDDEN SENSORINEURAL HEARING LOSS IN ITALIAN PATIENTS 82
Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 81
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS) 80
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 79
Antithrombotic therapy in diabetes: which, when, and for how long? 79
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 78
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 77
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation. 77
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 76
Increased thromboxane metabolites excretion in liver cirrhosis. 76
Simply read: erythrocytes modulate platelet function. Should we rethink the way we give aspirin? 76
Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. 76
Nonsteroidal antiinflammatory drugs: past, present and future 76
Measurement of Thromboxane Biosynthesis in Health and Disease 76
Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: A randomized clinical trial 76
Totale 11.169
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021601 0 0 0 0 0 54 115 27 140 50 181 34
2021/20221.145 157 93 13 73 86 32 32 187 44 33 175 220
2022/20232.133 313 301 176 241 175 237 75 172 257 43 95 48
2023/20241.357 43 348 42 179 80 132 97 29 28 69 136 174
2024/20252.510 61 54 196 89 199 67 36 155 416 214 556 467
2025/20263.885 1.124 208 530 733 1.056 234 0 0 0 0 0 0
Totale 15.422